Live feed
Filing
SC 13D/A
SC 13D/A0001185185-20-000116·Cellular Biomedicine Group, Inc.
Schedule 13D ownership disclosure
CELLULAR BIOMEDICINE GROUP I
Security class unavailable · CUSIP: 15117P102
Event date: 2020-01-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001185185-20-000116
- Form type
- SC 13D/A
- Filer
- Cellular Biomedicine Group, Inc.
- CIK
- CIK 1378624
- Filed
- Feb 03, 2020
- Reporting period
- Jan 28, 2020
- Description
- Schedule 13D beneficial ownership